Copyright for articles published in this journal is retained by the journal.
Author Biographies
Collares Thaís Farias
Laboratório de Imunodiagnóstico, Núcleo de Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Brazil, 96010-900, Pelotas, RS, - P.O. Box 354, Brazil
Monte Leonardo Garcia
Laboratório de Imunodiagnóstico, Núcleo de Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Brazil, 96010-900, Pelotas, RS, - P.O. Box 354, Brazil
Campos Vinicius Farias
Laboratório de Embriologia Molecular e Transgênese, Núcleo de Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Brazil, 96010-900, Pelotas, RS, - P.O. Box 354, Brazil
Seixas Fabiana Kömmiling
Laboratório de Genômica Funcional, Núcleo de Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Brazil, 96010-900, Pelotas, RS, - P.O. Box 354, Brazil
Collares Tiago Veiras
Laboratório de Embriologia Molecular e Transgênese, Núcleo de Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Brazil, 96010-900, Pelotas, RS, - P.O. Box 354, Brazil
Dellagostin Odir
Laboratório de Vacinologia, Núcleo de Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Brazil, 96010-900, Pelotas, RS, - P.O. Box 354, Brazil
Hartleben Cláudia Pinho
Laboratório de Imunodiagnóstico, Núcleo de Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Brazil, 96010-900, Pelotas, RS, - P.O. Box 354, Brazil
Main Article Content
Development of polyclonal antibodies for the detection of recombinant human erythropoietin
Collares Thaís Farias
Monte Leonardo Garcia
Campos Vinicius Farias
Seixas Fabiana Kömmiling
Collares Tiago Veiras
Dellagostin Odir
Hartleben Cláudia Pinho
Abstract
Recombinant human erythropoietin (rHuEPO) is detected by using direct pharmacological assays and indirect haematological assays. However, both methods have several limitations including technical challenges and cost-related issues. The aim of this study was to develop polyclonal antibodies against rHuEPO (anti-rHuEPO pAb) that can be used in immunoassays. In this study, we purified anti-rHuEPO pAb that could be used in immunoblotting assays to efficiently detect rHuEPO. Furthermore, these antirHuEPO pAb which could also detect rHuEPO that was expressed in a eukaryotic expression system (CHO cells). Thus, the anti-rHuEPO pAb developed in this study may be useful for rHuEPO detection.
Keywords: Antibodies, rHuEPO, immunoassays, pAb.
African Journal of Biotechnology Vol. 12(37), pp. 5595-5598
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.